Exelixis, Inc.EXEL is scheduled to report first-quarter 2017 results on May 1, after the market close. The company surpassed expectations thrice in the four trailing quarters and missed the same once, with an …
NASDAQ
78.40% of the stock is owned by institutional investors and hedge funds. Shares of Exelixis, Inc. (NASDAQ:EXEL) opened at 20.98 on Friday. …
Teachers Assurance
Exel Composites Plc has closed the transaction to acquire the Chinese composites production business of Nanjing Jianhui Composite Material (JHFRP). The acquisition was announced in a stock exchange release on …
China
This is just a quick sheet that you can plug in your shares, and whatever the going stock price is (green fields) and it will show you the effect pre …
Exelixis (EXEL) projected its fiscal 2017 costs and operating expenses to be in the range of $290 million–$310 million. This cost estimate includes …
Analyst Revenue Estimates
Today, Cann reiterated its Hold rating on Exelixis (NASDAQ:EXEL). There are 4 hold ratings, 6 buy ratings on the stock. The current consensus rating on Exelixis (NASDAQ:EXEL) is Buy (Score: 2.60) with a consensus …
NASDAQ
2. It's all about potential You might look at a biotech stock like Exelixis (NASDAQ: EXEL) and scratch your head. Exelixis boasts a market cap …
Over the first half-year, the activity of the EXEL Industries Group, which has suffered from the farming crisis, …
Exel